Welcome to our dedicated page for American Wtr Wks Co SEC filings (Ticker: AWK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Water Works Company (AWK) keeps more than 14 million people supplied with safe, reliable water—yet the details that move its share price live deep inside SEC documents. Whether you’re tracking how new rate cases fund pipeline replacement or measuring dividend sustainability, you’ll find every disclosure right here.
Stock Titan brings AI-powered summaries to each filing, turning dense accounting tables into clear takeaways. Need to monitor American Water Works insider trading Form 4 transactions or set alerts for American Water Works Form 4 insider transactions real-time? Our platform flags each entry within seconds of EDGAR release. Reviewing the next American Water Works quarterly earnings report 10-Q filing? We map revenue by regulated state and highlight capital-expenditure variances. For long-range analysis, the American Water Works annual report 10-K simplified view extracts rate-base growth, infrastructure spend and environmental commitments—all explained in plain language.
Common questions are answered as you scroll: American Water Works 8-K material events explained pinpoints new rate approvals; American Water Works proxy statement executive compensation breaks down pay versus performance metrics; our American Water Works earnings report filing analysis compares sequential operating margins; and �understanding American Water Works SEC documents with AI� is no longer a hurdle. From dividend investors watching cash-flow coverage to ESG analysts examining lead-service line replacement, comprehensive real-time coverage means you spend minutes, not hours, extracting insight.
Ladder Capital Corp (LADR) � Form 144 filing discloses that Suzanne Alexander intends to sell 26,795 Class A shares on or about 01 Aug 2025 through Rockefeller Financial on the NYSE. At the 144-quoted value of $291,041, the implied price is roughly $10.86 per share. LADR has 127.46 million shares outstanding, so the proposed sale equals ~0.02 % of the float.
The filer already disposed of 64,587 shares on 30-31 Jul 2025 for gross proceeds of $712,344, bringing total recent and planned sales to 91,382 shares (~0.07 % of shares outstanding) with proceeds approaching $1.0 million. All shares being sold were acquired via stock-based compensation awards or dividends granted between 2016-2023. No cash purchases were involved.
Form 144 filings merely signal an intention to sell and do not guarantee execution, yet repeated insider sales within days can be viewed as a modestly negative sentiment indicator. The filing contains no operational or financial performance data.
For Q2 2025, Green Brick Partners (GRBK) generated $549.1 million revenue (-2% YoY) and $81.9 million net income (-22%), with diluted EPS falling to $1.85. Residential unit revenue was flat, but heavier incentives lowered average selling price 5.3% and trimmed residential gross margin to 30.4% (-410 bps). Land & lot sales plunged 85%. Backlog revenue declined 21% to $516 million and units fell 18%, while the cancellation rate edged up to 9.9%.
Six-month revenue rose 5% to $1.047 billion, yet net income dropped 17% to $157.0 million; diluted EPS is $3.52 (-15%). Operating cash flow surged to $143 million versus $3 million last year, allowing $25 million senior-note pay-down and a $20 million reduction on credit lines; cash stands at $112 million and total debt at $276 million. Inventory grew 2% to $1.98 billion and equity increased to $1.75 billion. GRBK repurchased 1.03 million shares for $60.1 million, shrinking outstanding shares 2.1%; $39.9 million remains under the 2025 buy-back plan. The effective tax rate rose to 20.4%. Management is assessing effects of the newly enacted One Big Beautiful Bill Act.
American Water Works (AWK) Q2-25 10-Q highlights
Operating revenue climbed 11% YoY to $1.28 bn (H1 +12% to $2.42 bn) on newly implemented rate cases and modest customer growth. Operating income rose 9% to $489 m, but margin slipped 80 bp to 38.3%. Net income improved 4% to $289 m and diluted EPS hit $1.48 (H1 $2.53, +7%).
Cash from operations declined 13% to $632 m, pressured by higher receivables and working-capital swings, while capex remained heavy at $1.28 bn for network modernisation. Long-term debt fell $240 m to $12.28 bn, yet short-term borrowings rose $710 m, leaving total debt at $14.99 bn; equity increased to $10.68 bn.
Regulation & growth: 2025 general rate authorisations add $232 m in annualised revenue across IL, MO, IA, VA, IN, TN & HI; approved infrastructure surcharges add $38 m. Pending filings in KY ($27 m), WV ($48 m) and a multiyear CA request ($63 m in 2027 with potential $111 m thru 2029) could further expand the rate base. First-half interest income of $44 m from the $795 m 10% secured seller note (HOS sale) supports liquidity.
No new material litigation or risk factors were disclosed; management continues to target ~$3 bn annual capex and disciplined regulatory execution to drive long-term earnings and dividend growth.
Enliven Therapeutics, Inc. (ELVN) � Form 4 insider transaction. Chief Financial Officer Benjamin Hohl exercised 3,250 employee stock options at an exercise price of $2.48 per share and immediately sold the same 3,250 shares under a pre-arranged Rule 10b5-1 trading plan dated 26 Jun 2023.
- Option exercise: 3,250 shares converted from options granted 2 Aug 2021 (portion of a 262,120-share grant that vests monthly through Aug 2025).
- Sales: 3,052 shares sold at a volume-weighted average price (VWAP) of $20.8609 and 198 shares at a VWAP of $21.6583; individual trade ranges were $20.58-$21.575 and $21.5811-$21.788, respectively.
- Holdings after transactions: 23,000 shares of common stock held directly and 115,806 options outstanding.
- The exercise-and-sell was executed the same day (27 Jun 2025) and disclosed 1 Jul 2025.
The transaction represents routine liquidity management by the CFO; the net economic exposure (shares plus remaining options) remains substantial.